RT

RTW Biotech Opportunities Ltd

Overview

Corporate Details

ISIN(s):
GG00BKTRRM22
LEI:
549300Q7EXQQH6KF7Z84
Country:
United States of America
Address:
40 10TH AVE, 10014 NEW YORK
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

No description available.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for RTW Biotech Opportunities Ltd. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-22 08:00
Transaction in Own Shares
Transaction in Own Shares
English 10.6 KB
2025-08-19 08:01
Report Publication Announcement
Notice of Interim Results
English 13.6 KB
2025-08-19 08:00
Capital/Financing Update
Strategic Funding Agreement with Aquestive
English 15.0 KB
2025-08-15 08:00
Transaction in Own Shares
Transaction in Own Shares
English 10.6 KB
2025-08-14 08:00
Fund Information / Factsheet
Monthly Valuation Update and Factsheet
English 29.3 KB
2025-07-17 08:00
Regulatory News Service
Update on Kailera Therapeutics
English 15.4 KB
2025-07-15 08:00
Fund Information / Factsheet
Monthly Valuation Update and Factsheet
English 32.5 KB
2025-07-10 08:00
M&A Activity
Merck to acquire Verona Pharma
English 15.7 KB
2025-07-03 18:34
Major Shareholding Notification
Holding(s) in Company
English 51.0 KB
2025-03-31 08:00
Annual Report
Annual Financial Report
English 1.6 MB
2025-03-28 08:00
Transaction in Own Shares
Transaction in Own Shares
English 10.6 KB
2025-03-26 08:00
Transaction in Own Shares
Transaction in Own Shares
English 10.6 KB

Automate Your Workflow. Get a real-time feed of all RTW Biotech Opportunities Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for RTW Biotech Opportunities Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Cantargia Logo
Develops antibody-based drugs targeting IL1RAP for cancer and inflammatory diseases.
Sweden CANTA
Captor Therapeutics S.A. Logo
Develops TPD drugs for oncology and autoimmune disorders, targeting 'undruggable' proteins.
Poland CTX
Developing engineered cellular medicines for regenerative treatment of heart failure.
United Kingdom N/A
Cellectis Logo
Biopharma using gene-editing to create off-the-shelf CAR T-cell cancer therapies.
France ALCLS
Celyad Oncology SA Logo
Clinical-stage biotech developing allogeneic & autologous CAR T-cell therapies for cancer.
Belgium CYAD
Cereno Scientific AB Logo
Clinical-stage biotech developing treatments for rare cardiovascular & pulmonary diseases.
Sweden CRNO
Ceres Power Holdings PLC Logo
Licensing solid oxide tech (SOFC/SOEC) for clean power and green hydrogen to global partners.
United Kingdom CWR
Cessatech A/S Logo
Develops non-invasive pain relief, like a nasal spray, for children.
Denmark CESSA
CHOSA Oncology AB Logo
Develops diagnostics and drug delivery for personalized cancer therapy.
Sweden CHOSA
Cinclus Pharma Holding AB Logo
Late-stage pharma developing a next-gen P-CAB drug for severe GERD and H. pylori.
Sweden CINPHA